Effect of Blockage of Notch1 Signaling on the Activation of T Cellular Immunity in Peripheral Blood Mononuclear Cells of Patients with Chronic Hepatitis B

LIU Xue-ni,PEI Jin-xian,LI Xiao-liang,ZANG Guo-qing,YU Yong-sheng
2011-01-01
Abstract:AIM: To investigate the influence of Notch1 signaling on expression of T-bet,Th1-and Th2-type cytokines and cytotoxic T-lymphocyte(CTL) cytotoxicity of peripheral blood mononuclear cells(PBMC) of patients with chronic hepatitis B,and analyze the possible function of Notch1 signaling on regulating the activation of T cellular immunity. METHODS: PBMC of patients with chronic hepatitis B were divided into test group,negative control group and blank control group,respectively was given anti-Notch1,IgG2b and RPMI-1640.The expression of T-bet mRNA was examined by real-time PCR,Th1-type cytokines IFN-γ,IL-2,Th2-type cytokines IL-4,IL-10 were assayed by enzyme-linked immunosorbent assay(ELISA) and CTL cytotoxicity was measured by Cytotoxicity Detection Assay(LDH).RESULTS:After Notch1 signaling of PBMC was blocked in chronic hepatitis B patients,expression of T-bet mRNA and the production of Th1-type cytokines IFN-γ,IL-2 were enhanced while Th2-type cytokines IL-4,IL-10 were decreased,and CTL cytotoxicity was enhanced,compared with the blank control groups(P0.01).CONCLUSION: After blocking of Notch1 signaling of PBMC of chronic hepatitis B patients,the expression of T-bet mRNA and the production of Th1-type cytokines IFN-γ,IL-2 were increased,while Th2-type cytokines IL-4,IL-10 were decreased and CTL cytotoxicity was enhanced.It suggested that blockage of Notch1 signaling could activate T cellular immunity of patients with chronic hepatitis B,Notch1 signaling might contribute to immune tolerance of patients with chronic hepatitis B,perhaps related with T-bet.
What problem does this paper attempt to address?